Nautilus Biotechnology Announces Layoffs Amid Strategic Restructuring

Nautilus Biotechnology, a prominent life sciences company headquartered in San Carlos, California, has announced plans to lay off 133 employees across its Seattle, WA corporate and software operations, as well as its San Carlos, CA research and development center. This decision is part of a strategic restructuring aimed at optimizing resources and focusing on key projects.

Founded in 2016, Nautilus Biotechnology specializes in developing advanced platforms for analyzing human proteins, integrating computer science and biochemistry to revolutionize proteomic analysis. The company maintains corporate headquarters in Seattle and research facilities in San Carlos.

The layoffs are expected to impact various departments, including research and development, software engineering, and corporate services. Nautilus Biotechnology has stated that affected employees will receive severance packages and assistance with job placement to support their transition.

This move reflects a broader trend in the biotechnology sector, where companies are reassessing their operational strategies to navigate financial challenges and shifting market demands.

Nautilus Biotechnology remains committed to advancing its mission of transforming proteomic analysis and continues to invest in its core research initiatives.